Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Case Reports in Dermatology
|
February 11, 2026
Successful Alternative Administration of Sonidegib in a Patient with Gorlin-Goltz Syndrome and Dysphagia: A Case Report
Armin Bender, Lisa Krönig
Cancers
|
December 11, 2025
Structured Symptom Assessment in Dermato-Oncology Patients-A Prospective Observational Study of the Usability of a Symptom Questionnaire
Martin Gschnell, Jannis Thole, Lisa Kroenig, et al.
European Journal of Dermatology : EJD
|
October 17, 2018
Adjuvant high-dose intravenous immunoglobulins for recalcitrant erosive oral lichen planus: mixed clinical responses
Armin Bender, Caroline Fix, Verena Eubel, et al.
International Journal of Cancer
|
September 10, 2005
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011
Julia Karbach, Claudia Pauligk, Armin Bender, et al.
Psycho-Oncology
|
December 4, 2015
Comparison of patient-reported need of psycho-oncologic support and the doctor's perspective: how do they relate to disease severity in melanoma patients?
Sandra Nolte, Sicco H van der Mei, Kerstin Strehl-Schwarz, et al.
Cancer Research
|
May 4, 2005
Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma
Salah-Eddin Al-Batran, Mohammad-Reza Rafiyan, Akin Atmaca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2010
Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients
Julia Karbach, Antje Neumann, Akin Atmaca, et al.
International Journal of Cancer
|
July 21, 2007
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination
Julia Karbach, Sacha Gnjatic, Claudia Pauligk, et al.
International Journal of Cancer
|
September 4, 2009
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival
Julia Karbach, Sacha Gnjatic, Armin Bender, et al.
The Journal of Experimental Medicine
|
May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells
Beatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Case Reports in Dermatology
|
February 11, 2026
Successful Alternative Administration of Sonidegib in a Patient with Gorlin-Goltz Syndrome and Dysphagia: A Case Report
Armin Bender, Lisa Krönig
Cancers
|
December 11, 2025
Structured Symptom Assessment in Dermato-Oncology Patients-A Prospective Observational Study of the Usability of a Symptom Questionnaire
Martin Gschnell, Jannis Thole, Lisa Kroenig, et al.
European Journal of Dermatology : EJD
|
October 17, 2018
Adjuvant high-dose intravenous immunoglobulins for recalcitrant erosive oral lichen planus: mixed clinical responses
Armin Bender, Caroline Fix, Verena Eubel, et al.
International Journal of Cancer
|
September 10, 2005
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011
Julia Karbach, Claudia Pauligk, Armin Bender, et al.
Psycho-Oncology
|
December 4, 2015
Comparison of patient-reported need of psycho-oncologic support and the doctor's perspective: how do they relate to disease severity in melanoma patients?
Sandra Nolte, Sicco H van der Mei, Kerstin Strehl-Schwarz, et al.
Cancer Research
|
May 4, 2005
Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma
Salah-Eddin Al-Batran, Mohammad-Reza Rafiyan, Akin Atmaca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2010
Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients
Julia Karbach, Antje Neumann, Akin Atmaca, et al.
International Journal of Cancer
|
July 21, 2007
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination
Julia Karbach, Sacha Gnjatic, Claudia Pauligk, et al.
International Journal of Cancer
|
September 4, 2009
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival
Julia Karbach, Sacha Gnjatic, Armin Bender, et al.
The Journal of Experimental Medicine
|
May 22, 2002
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells
Beatrice Schuler-Thurner, Erwin S Schultz, Thomas G Berger, et al.
Page
of 2